Lecture 12 2/10/25 Flashcards

1
Q

What are the different classifications for hepatobiliary dz?

A

-inflammatory vs. non-inflammatory
-hepatocellular vs vascular vs biliary
-primary vs secondary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does the occurrence of primary vs secondary hepatobiliary dz differ between dogs and cats?

A

-dogs are more likely to have inc. liver enzymes due to secondary dz
-cats are more likely to have inc. liver enzymes due to primary dz

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are hepatic vascular diseases?

A

-conditions causing abnormal blood flow within or around the liver
-lead to liver atrophy and buildup of toxins within the system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the congenital hepatic vascular diseases?

A

-macroscopic congenital portosystemic shunts; extrahepatic and intrahepatic
-primary portal vein hypoplasia; with or without portal hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the acquired hepatic vascular disease?

A

multiple extrahepatic shunts, secondary to hepatic fibrosis or hepatic arteriovenous malformations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the characteristics of CPSS etiology?

A

-heritable disease
-single genetic causal mutation NOT identified
-likely has a complex polygenic etiology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the pathophysiology of hepatic venous hypoperfusion?

A

-leads to decreased hepatic clearance of nutrients and waste products from GI portal drainage
-can leads to reduced hepatic size, histologic changes in the liver, and alteration of normal metabolic function
-can cause hepatic encephalopathy due to decreased metabolism of ammonia and other substances from portal circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the pathophysiology of microvascular dysplasia?

A

-abnormal blood flow through the hepatic sinusoids
-minimal systemic consequences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the clinical presentation of extrahepatic CPSS?

A

-usually identified within first 2 years of life
-can be detected at any age
-more common in small breeds
-no gender predisposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the clinical presentation of intrahepatic CPSS?

A

-usually more severe signs
-detected before 1 year of age
-more common in large breeds
-no gender predisposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the clinical presentation of microvascular dysplasia?

A

-same signalment as small breed dogs with extrahepatic CPSS
-can occur simultaneously with extrahepatic CPSS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the neurologic signs seen in patients with hepatic vascular dz?

A

-reduced mentation
-altered behavior
-ataxia
-head pressing
-circling
-tremors
-blindness
-seizures
-coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the GI signs seen in patients with hepatic vascular dz?

A

-vomiting
-diarrhea
-pica
-GI bleeding/melena

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the urinary tract signs seen in patients with hepatic vascular dz?

A

-hematuria
-dysuria
-stranguria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the miscellaneous clinical signs seen with hepatic vascular dz?

A

-PU/PD
-small stature
-poor BCS
-intolerance to sedatives/anesthetics
-hypersalivation
-copper-colored irises
-intermittent pyrexia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the differential diagnoses for hepatic vascular dz based on clinical signs?

A

-reactive hepatopathy
-portal hypertension with multiple acquired PSS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the common abnormalities found on CBC/chem/UA in animals with CPSS?

A

-microcytosis +/- anemia
-hypoalbuminemia
-decreased BUN
-hypocholesterolemia
-hypoglycemia
-increased liver enzyme activities
-low USG
-ammonium biurate crystals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are more specific tests that can be run in patients with suspected hepatic vascular dz/CPSS?

A

-paired total serum bile acids (rule out parenchymal hepatic dz and cholestasis)
-plasma NH3
-protein C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the characteristics of CT angiography for patients with vascular dz/PSS?

A

-gold standard imaging modality
-used for surgical planning of shunt attenuation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the characteristics of abdominal ultrasound for patients with vascular dz/PSS?

A

-operator dependent
-can identify microhepatica, renomegaly, nephrolithiasis, urolithiasis, and decreased portal vein to aorta ratio

21
Q

What are the limitations of trans-splenic scintigraphy?

A

-use of radionuclide
-suboptimal shunt localization

22
Q

What are the characteristics of microvascular dysplasia?

A

-malformed intrahepatic portal microvasculature
-usually no signs of illness
-possible to see mild increase of hepatic transaminases
-no other clin path abnormalities
-serum bile acids elevated

23
Q

How is microvascular dysplasia diagnosed/managed?

A

-protein C to distinguish from macroscopic PSS
-CT angiography/scintigraphy to confirm
-no specific therapy indicated; be careful with use of drugs metabolized via liver

24
Q

What are the characteristics of PSS medical management?

A

-should be done in all dogs with PSS regardless of whether attenuation sx is planned
-lifelong if attenuation is not an option
-goal is to reduce elevated systemic NH3
-involves dietary modification, acceleration of GI transit, and modulation of gut microbiota

25
Q

What are the three goals when managing hepatic encephalopathy?

A

-reduce incidence of predisposing factors
-alleviate neurologic signs
-identify underlying hepatic condition for more specific management

26
Q

What are the characteristics of appropriate nutrition for patients with PSS?

A

-commercially available liver diets are a good starting point
-start low with protein and gradually increase to levels that can be tolerated without causing hepatic encephalopathy signs
-soy and dairy proteins are mest
-avoid red meat, fish, and organ meat

27
Q

Which products can be used for gut microbiota modulation?

A

-antibiotics
-probiotics

28
Q

What are the characteristics of nonabsorbable disaccharides?

A

-laxative effects decrease gut transit time
-decrease activity of bacterial ureases and enteric peptidases to increase bacterial nitrogen fixation
-acidify enteric pH to trap ammonia in the gut as ammonium ions and prevent absorption

29
Q

What are the treatment steps for patients with severe overt encephalopathy?

A

-fluids
-elevate head to reduce aspiration risk
-IV antibiotics to modify gut flora
-cleansing enema
-lactulose retention enemas to reduce NH3 resorption

30
Q

What are the treatment options for pets experiencing seizures due to hepatic encephalopathy?

A

-IV levetiracetam
-propofol CRI
-mannitol to induce osmotic diuresis

31
Q

Why should benzos be avoided in seizuring patients?

A

they can worsen the encephalopathy signs

32
Q

What are the surgical options for extrahepatic congenital PSS attenuation?

A

-silk suture ligation
-ameroid constrictor application
-cellophane banding

33
Q

What are the surgical options for intrahepatic congenital PSS attenuation?

A

-suture ligation
-endovascular coil embolization

34
Q

What are the perioperative management steps for patients undergoing shunt attenuation?

A

-levetiracetam for at least 1 day prior to surgery to reduce post-op seizure risk
-proton pump inhibitors pre- and post-op to decrease incidence of GI ulcers
-post-op rechecks at 2 weeks, 1 month, 3 months, and 6 months
-tapering of medical therapy as signs improve
-protein C evaluation at re-checks
-additional surgery or medical management in animals not improving

35
Q

What is the prognosis of hepatic vascular dz?

A

-depends on severity of signs and management strategy
-PSS attenuation provides longer survival than medical management
-microvascular dysplasia has good prognosis

36
Q

What is acute liver injury?

A

severe hepatocellular damage in a patient without previous hx of liver dz

37
Q

What does acute liver failure manifest with?

A

-hyperbilirubinemia
-impaired coagulation
-overt hepatic encephalopathy

38
Q

What are the most common causes of ALI/ALF?

A

-toxic
-infectious
-neoplastic
-idiopathic

39
Q

What is the pathophysiology of ALI/ALF?

A

-severe acute hepatocellular injury results in cell death and organ dysfunction
-death and dysfunction leads to synthetic failure
-mechanism of action varies with etiology

40
Q

What are the clinical signs of ALI/ALF?

A

-acute hepatic encephalopathy
-acute GI signs
-icterus
-ascites
-hypotension
-circulatory/hemorrhagic shock

41
Q

What is the clin path seen in ALI/ALF patients?

A

-increased leakage enzymes; ALT, AST
-abnormal liver function parameters; decreased GUAC, increased bilirubin
-abnormal coagulation; prolonged PT/PTT, decreased fibrinogen

42
Q

What is seen on diagnostic imaging in patients with ALI/ALF?

A

-often non-specific
-normal or enlarged liver size
-rounded edges
-diffusely hypo- or hyperechoic

43
Q

How is ALI/ALF diagnosed?

A

Presumptive:
-history
-clinical signs
-clin path +/- cytology
-diagnostic imaging
Definitive:
-liver biopsy

44
Q

What are the treatment steps for ALI/ALF patients?

A

-fluid therapy
-vasopressors for hypotension not responding to fluids
-decontamination in toxin ingestion cases
-antidotes for intoxication/ingestion where indicated
-hepatoprotectants
-vitamin K if coagulation is abnormal

45
Q

What is the treatment for hepatic encephalopathy?

A

mild, overt: oral lactulose and GI flora modulation
severe, overt: intensive supportive care

46
Q

What are the treatment options available for patients with secondary conditions such as GI ulcers and ascites?

A

GI ulceration: omeprazole and antiemetics
ascites: spironolactone +/- furosemide

47
Q

Why is it questionable to use antibiotics in ALI/ALF patients?

A

-reason for wanting to use antibiotics is to protect against infectious complications
-cannot use agents metabolized by liver or that are hepatotoxic; limits drug choices

48
Q

What should be monitored in ALI/ALF patients?

A

-CBC
-chem
-UA
-coag. panel
-hepatic transaminase reduction
-bilirubin and hepatic synthetic factors

49
Q

What is the prognosis for ALI/ALF?

A

-variable
-severely elevated transaminases are NOT poor prognostic indicators
-normal albumin in ALF is a good survival indicator